Overview

Clarithromycin-based Triple Therapy for 14 Days Versus Sequential Therapy 10 Days in the First Line Therapy

Status:
Unknown status
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The investigators aimed to compare the eradication rates of sequential therapy for 10 days versus triple therapy for 14 days
Phase:
Phase 4
Details
Lead Sponsor:
National Taiwan University Hospital
Treatments:
Amoxicillin
Clarithromycin
Dexlansoprazole
Lansoprazole
Metronidazole